112 related articles for article (PubMed ID: 16949120)
21. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model.
Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ
Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
[TBL] [Abstract][Full Text] [Related]
23. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
Li YG; Tian FL; Gao FS; Tang XS; Xia C
Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
[TBL] [Abstract][Full Text] [Related]
24. Antibody titres against canine papillomavirus 1 peak around clinical regression in naturally occurring oral papillomatosis.
Sancak A; Favrot C; Geisseler MD; Müller M; Lange CE
Vet Dermatol; 2015 Feb; 26(1):57-9, e19-20. PubMed ID: 25496468
[TBL] [Abstract][Full Text] [Related]
25. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
26. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
27. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
[TBL] [Abstract][Full Text] [Related]
28. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immune responses in rainbow trout after DNA immunization against the viral hemorrhagic septicemia virus.
Utke K; Kock H; Schuetze H; Bergmann SM; Lorenzen N; Einer-Jensen K; Köllner B; Dalmo RA; Vesely T; Ototake M; Fischer U
Dev Comp Immunol; 2008; 32(3):239-52. PubMed ID: 17629943
[TBL] [Abstract][Full Text] [Related]
30. Canine adenovirus based rabies vaccines.
Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
[TBL] [Abstract][Full Text] [Related]
31. Superiority of needle-free transdermal plasmid delivery for the induction of antigen-specific IFNgamma T cell responses in the dog.
Goubier A; Fuhrmann L; Forest L; Cachet N; Evrad-Blanchard M; Juillard V; Fischer L
Vaccine; 2008 Apr; 26(18):2186-90. PubMed ID: 18395307
[TBL] [Abstract][Full Text] [Related]
32. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
Tsang C; Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel P
Vaccine; 2007 Jul; 25(30):5485-94. PubMed ID: 17408815
[TBL] [Abstract][Full Text] [Related]
33. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
34. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
[TBL] [Abstract][Full Text] [Related]
35. Oral DNA immunization in the second trimester fetal lamb and secondary immune responses in the neonate.
Tsang CH; Mirakhur KK; Babiuk LA; Griebel PJ
Vaccine; 2007 Dec; 25(50):8469-79. PubMed ID: 17950962
[TBL] [Abstract][Full Text] [Related]
36. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
Kawahara M
Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
[TBL] [Abstract][Full Text] [Related]
37. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
39. Cell mediated immune response following foot-and-mouth disease vaccination in buffalo calves.
Sharma R; Prasad S; Ahuja KL; Rahman MM; Kumar A
Acta Virol; 1985 Dec; 29(6):509-13. PubMed ID: 2869664
[TBL] [Abstract][Full Text] [Related]
40. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
